Prismatic correction in patients affected by age-related macular degeneration

Maurizio Battaglia Parodi, Lisa Toto, Leonardo Mastropasqua, Marta Depollo, Giuseppe Ravalico

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Objective: To evaluate by means of a controlled clinical trial the effectiveness and the tolerance of prismatic correction in improving visual function in patients affected by advanced bilateral age-related macular degeneration. Setting: Department of Ophthalmology, Eye Clinic, University of Trieste. Subjects and interventions: Each patient underwent an ophthalmologic examination, complete with distance visual acuity measurement using the Standard Early Treatment Diabetic Retinopathy Study chart. Patients were then randomly assigned to the treatment or control group. The treatment group received spectacles lenses with a prismatic correction of low power (5-7 prismatic dioptres) in the better eye. Main measures: Visual acuity was measured at baseline and 1, 90, 180 and 360 days after prescription in both groups. Results: The treatment group consisted of 14 patients, while the control group was of 14 patients. The prismatic correction was well tolerated in 85.7% of cases. Visual acuity in the treatment group improved mostly at three-month follow-up, with a slight further improvement at the six- and 12-month follow-ups, showing a statistically significant difference in comparison with the control group. No visual acuity improvement was registered in the control group. Conclusion: Monolateral prismatic correction may be considered a viable means to improve visual function im patients affected by bilateral age-related macular degeneration at an advanced stage.

Original languageEnglish
Pages (from-to)828-832
Number of pages5
JournalClinical Rehabilitation
Volume18
Issue number7
DOIs
Publication statusPublished - Nov 2004

Fingerprint

Macular Degeneration
Visual Acuity
Control Groups
Therapeutics
Controlled Clinical Trials
Diabetic Retinopathy
Ophthalmology
Lenses
Prescriptions

ASJC Scopus subject areas

  • Rehabilitation
  • Health Professions(all)

Cite this

Prismatic correction in patients affected by age-related macular degeneration. / Parodi, Maurizio Battaglia; Toto, Lisa; Mastropasqua, Leonardo; Depollo, Marta; Ravalico, Giuseppe.

In: Clinical Rehabilitation, Vol. 18, No. 7, 11.2004, p. 828-832.

Research output: Contribution to journalArticle

Parodi, Maurizio Battaglia ; Toto, Lisa ; Mastropasqua, Leonardo ; Depollo, Marta ; Ravalico, Giuseppe. / Prismatic correction in patients affected by age-related macular degeneration. In: Clinical Rehabilitation. 2004 ; Vol. 18, No. 7. pp. 828-832.
@article{991cc1f9f02445cba4511192dfba4752,
title = "Prismatic correction in patients affected by age-related macular degeneration",
abstract = "Objective: To evaluate by means of a controlled clinical trial the effectiveness and the tolerance of prismatic correction in improving visual function in patients affected by advanced bilateral age-related macular degeneration. Setting: Department of Ophthalmology, Eye Clinic, University of Trieste. Subjects and interventions: Each patient underwent an ophthalmologic examination, complete with distance visual acuity measurement using the Standard Early Treatment Diabetic Retinopathy Study chart. Patients were then randomly assigned to the treatment or control group. The treatment group received spectacles lenses with a prismatic correction of low power (5-7 prismatic dioptres) in the better eye. Main measures: Visual acuity was measured at baseline and 1, 90, 180 and 360 days after prescription in both groups. Results: The treatment group consisted of 14 patients, while the control group was of 14 patients. The prismatic correction was well tolerated in 85.7{\%} of cases. Visual acuity in the treatment group improved mostly at three-month follow-up, with a slight further improvement at the six- and 12-month follow-ups, showing a statistically significant difference in comparison with the control group. No visual acuity improvement was registered in the control group. Conclusion: Monolateral prismatic correction may be considered a viable means to improve visual function im patients affected by bilateral age-related macular degeneration at an advanced stage.",
author = "Parodi, {Maurizio Battaglia} and Lisa Toto and Leonardo Mastropasqua and Marta Depollo and Giuseppe Ravalico",
year = "2004",
month = "11",
doi = "10.1191/0269215504cr801oa",
language = "English",
volume = "18",
pages = "828--832",
journal = "Clinical Rehabilitation",
issn = "0269-2155",
publisher = "SAGE Publications Ltd STM",
number = "7",

}

TY - JOUR

T1 - Prismatic correction in patients affected by age-related macular degeneration

AU - Parodi, Maurizio Battaglia

AU - Toto, Lisa

AU - Mastropasqua, Leonardo

AU - Depollo, Marta

AU - Ravalico, Giuseppe

PY - 2004/11

Y1 - 2004/11

N2 - Objective: To evaluate by means of a controlled clinical trial the effectiveness and the tolerance of prismatic correction in improving visual function in patients affected by advanced bilateral age-related macular degeneration. Setting: Department of Ophthalmology, Eye Clinic, University of Trieste. Subjects and interventions: Each patient underwent an ophthalmologic examination, complete with distance visual acuity measurement using the Standard Early Treatment Diabetic Retinopathy Study chart. Patients were then randomly assigned to the treatment or control group. The treatment group received spectacles lenses with a prismatic correction of low power (5-7 prismatic dioptres) in the better eye. Main measures: Visual acuity was measured at baseline and 1, 90, 180 and 360 days after prescription in both groups. Results: The treatment group consisted of 14 patients, while the control group was of 14 patients. The prismatic correction was well tolerated in 85.7% of cases. Visual acuity in the treatment group improved mostly at three-month follow-up, with a slight further improvement at the six- and 12-month follow-ups, showing a statistically significant difference in comparison with the control group. No visual acuity improvement was registered in the control group. Conclusion: Monolateral prismatic correction may be considered a viable means to improve visual function im patients affected by bilateral age-related macular degeneration at an advanced stage.

AB - Objective: To evaluate by means of a controlled clinical trial the effectiveness and the tolerance of prismatic correction in improving visual function in patients affected by advanced bilateral age-related macular degeneration. Setting: Department of Ophthalmology, Eye Clinic, University of Trieste. Subjects and interventions: Each patient underwent an ophthalmologic examination, complete with distance visual acuity measurement using the Standard Early Treatment Diabetic Retinopathy Study chart. Patients were then randomly assigned to the treatment or control group. The treatment group received spectacles lenses with a prismatic correction of low power (5-7 prismatic dioptres) in the better eye. Main measures: Visual acuity was measured at baseline and 1, 90, 180 and 360 days after prescription in both groups. Results: The treatment group consisted of 14 patients, while the control group was of 14 patients. The prismatic correction was well tolerated in 85.7% of cases. Visual acuity in the treatment group improved mostly at three-month follow-up, with a slight further improvement at the six- and 12-month follow-ups, showing a statistically significant difference in comparison with the control group. No visual acuity improvement was registered in the control group. Conclusion: Monolateral prismatic correction may be considered a viable means to improve visual function im patients affected by bilateral age-related macular degeneration at an advanced stage.

UR - http://www.scopus.com/inward/record.url?scp=9144252709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9144252709&partnerID=8YFLogxK

U2 - 10.1191/0269215504cr801oa

DO - 10.1191/0269215504cr801oa

M3 - Article

C2 - 15573840

AN - SCOPUS:9144252709

VL - 18

SP - 828

EP - 832

JO - Clinical Rehabilitation

JF - Clinical Rehabilitation

SN - 0269-2155

IS - 7

ER -